HSPA5 and liver dysplastic nodule: These results suggest that DcR2 is a specific marker of apoptotic resistance in senescent RTECs and that targeting the DcR2–GRP78 axis to eliminate senescent RTECs is a promising therapeutic strategy for the prevention and treatment of DN.